Copyright Reports & Markets. All rights reserved.

Global Hereceptin Biosimilar Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Market Overview

    • 1.1 Hereceptin Biosimilar Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Tablet
      • 1.2.2 Capsule
    • 1.3 Market Analysis by Applications
      • 1.3.1 Pharmaceuticals
      • 1.3.2 Healthcare
      • 1.3.3 Others
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Mylan N.V.
      • 2.1.1 Business Overview
      • 2.1.2 Hereceptin Biosimilar Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Mylan N.V. Hereceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 AryoGen Biopharma
      • 2.2.1 Business Overview
      • 2.2.2 Hereceptin Biosimilar Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 AryoGen Biopharma Hereceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Genor Biopharma
      • 2.3.1 Business Overview
      • 2.3.2 Hereceptin Biosimilar Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Genor Biopharma Hereceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Celltrion Inc.
      • 2.4.1 Business Overview
      • 2.4.2 Hereceptin Biosimilar Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Celltrion Inc. Hereceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Amgen Inc.
      • 2.5.1 Business Overview
      • 2.5.2 Hereceptin Biosimilar Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Amgen Inc. Hereceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Mabion S.A.
      • 2.6.1 Business Overview
      • 2.6.2 Hereceptin Biosimilar Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Mabion S.A. Hereceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 The Instituto Vital Brazil
      • 2.7.1 Business Overview
      • 2.7.2 Hereceptin Biosimilar Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 The Instituto Vital Brazil Hereceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 F. Hoffmann-La Roche AG
      • 2.8.1 Business Overview
      • 2.8.2 Hereceptin Biosimilar Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 F. Hoffmann-La Roche AG Hereceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Biocon
      • 2.9.1 Business Overview
      • 2.9.2 Hereceptin Biosimilar Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Biocon Hereceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Gedeon Richter Plc
      • 2.10.1 Business Overview
      • 2.10.2 Hereceptin Biosimilar Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Gedeon Richter Plc Hereceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Hereceptin Biosimilar Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Hereceptin Biosimilar Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Hereceptin Biosimilar Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Hereceptin Biosimilar Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Hereceptin Biosimilar Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Hereceptin Biosimilar Market Analysis by Regions

    • 4.1 Global Hereceptin Biosimilar Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Hereceptin Biosimilar Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Hereceptin Biosimilar Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Hereceptin Biosimilar Sales and Growth Rate (2014-2019)
    • 4.3 Europe Hereceptin Biosimilar Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Hereceptin Biosimilar Sales and Growth Rate (2014-2019)
    • 4.5 South America Hereceptin Biosimilar Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Hereceptin Biosimilar Sales and Growth Rate (2014-2019)

    5 North America Hereceptin Biosimilar by Country

    • 5.1 North America Hereceptin Biosimilar Sales, Revenue and Market Share by Country
      • 5.1.1 North America Hereceptin Biosimilar Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Hereceptin Biosimilar Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Hereceptin Biosimilar Sales and Growth Rate (2014-2019)
    • 5.3 Canada Hereceptin Biosimilar Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Hereceptin Biosimilar Sales and Growth Rate (2014-2019)

    6 Europe Hereceptin Biosimilar by Country

    • 6.1 Europe Hereceptin Biosimilar Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Hereceptin Biosimilar Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Hereceptin Biosimilar Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Hereceptin Biosimilar Sales and Growth Rate (2014-2019)
    • 6.3 UK Hereceptin Biosimilar Sales and Growth Rate (2014-2019)
    • 6.4 France Hereceptin Biosimilar Sales and Growth Rate (2014-2019)
    • 6.5 Russia Hereceptin Biosimilar Sales and Growth Rate (2014-2019)
    • 6.6 Italy Hereceptin Biosimilar Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Hereceptin Biosimilar by Country

    • 7.1 Asia-Pacific Hereceptin Biosimilar Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Hereceptin Biosimilar Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Hereceptin Biosimilar Revenue and Market Share by Country (2014-2019)
    • 7.2 China Hereceptin Biosimilar Sales and Growth Rate (2014-2019)
    • 7.3 Japan Hereceptin Biosimilar Sales and Growth Rate (2014-2019)
    • 7.4 Korea Hereceptin Biosimilar Sales and Growth Rate (2014-2019)
    • 7.5 India Hereceptin Biosimilar Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Hereceptin Biosimilar Sales and Growth Rate (2014-2019)

    8 South America Hereceptin Biosimilar by Country

    • 8.1 South America Hereceptin Biosimilar Sales, Revenue and Market Share by Country
      • 8.1.1 South America Hereceptin Biosimilar Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Hereceptin Biosimilar Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Hereceptin Biosimilar Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Hereceptin Biosimilar Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Hereceptin Biosimilar Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Hereceptin Biosimilar by Countries

    • 9.1 Middle East and Africa Hereceptin Biosimilar Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Hereceptin Biosimilar Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Hereceptin Biosimilar Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Hereceptin Biosimilar Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Hereceptin Biosimilar Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Hereceptin Biosimilar Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Hereceptin Biosimilar Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Hereceptin Biosimilar Sales and Growth Rate (2014-2019)

    10 Global Hereceptin Biosimilar Market Segment by Type

    • 10.1 Global Hereceptin Biosimilar Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Hereceptin Biosimilar Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Hereceptin Biosimilar Revenue and Market Share by Type (2014-2019)
    • 10.2 Tablet Sales Growth and Price
      • 10.2.1 Global Tablet Sales Growth (2014-2019)
      • 10.2.2 Global Tablet Price (2014-2019)
    • 10.3 Capsule Sales Growth and Price
      • 10.3.1 Global Capsule Sales Growth (2014-2019)
      • 10.3.2 Global Capsule Price (2014-2019)

    11 Global Hereceptin Biosimilar Market Segment by Application

    • 11.1 Global Hereceptin Biosimilar Sales Market Share by Application (2014-2019)
    • 11.2 Pharmaceuticals Sales Growth (2014-2019)
    • 11.3 Healthcare Sales Growth (2014-2019)
    • 11.4 Others Sales Growth (2014-2019)

    12 Hereceptin Biosimilar Market Forecast (2019-2024)

    • 12.1 Global Hereceptin Biosimilar Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Hereceptin Biosimilar Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Hereceptin Biosimilar Market Forecast (2019-2024)
      • 12.2.2 Europe Hereceptin Biosimilar Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Hereceptin Biosimilar Market Forecast (2019-2024)
      • 12.2.4 South America Hereceptin Biosimilar Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Hereceptin Biosimilar Market Forecast (2019-2024)
    • 12.3 Hereceptin Biosimilar Market Forecast by Type (2019-2024)
      • 12.3.1 Global Hereceptin Biosimilar Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Hereceptin Biosimilar Market Share Forecast by Type (2019-2024)
    • 12.4 Hereceptin Biosimilar Market Forecast by Application (2019-2024)
      • 12.4.1 Global Hereceptin Biosimilar Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Hereceptin Biosimilar Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Scope of the Report:
      The worldwide market for Hereceptin Biosimilar is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study.
      This report focuses on the Hereceptin Biosimilar in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

      Market Segment by Manufacturers, this report covers
      Mylan N.V.
      AryoGen Biopharma
      Genor Biopharma
      Celltrion Inc.
      Amgen Inc.
      Mabion S.A.
      The Instituto Vital Brazil
      F. Hoffmann-La Roche AG
      Biocon
      Gedeon Richter Plc

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia etc.)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Tablet
      Capsule

      Market Segment by Applications, can be divided into
      Pharmaceuticals
      Healthcare
      Others

      The content of the study subjects, includes a total of 15 chapters:
      Chapter 1, to describe Hereceptin Biosimilar product scope, market overview, market opportunities, market driving force and market risks.
      Chapter 2, to profile the top manufacturers of Hereceptin Biosimilar, with price, sales, revenue and global market share of Hereceptin Biosimilar in 2017 and 2018.
      Chapter 3, the Hereceptin Biosimilar competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
      Chapter 4, the Hereceptin Biosimilar breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
      Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
      Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
      Chapter 12, Hereceptin Biosimilar market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
      Chapter 13, 14 and 15, to describe Hereceptin Biosimilar sales channel, distributors, customers, research findings and conclusion, appendix and data source.

      Buy now